Education > Webinar > Navigating the Complexity of the GI Microbiome in Clinical Practice

Navigating the Complexity of the GI Microbiome in Clinical Practice

Throughout the heavy research process during the development of the GI EcologiX, there were many discoveries which we will share with you throughout this free webinar.


When
28th January 2020
6:30 pm GMT

Description


At Invivo we pride ourselves in translating the wealth of complex information around the GI microbiome into clinical relevance. Client outcomes govern what we do and with this in mind, we created a new GI profile called GI EcologiX™.

Throughout the heavy research process during development, there were many discoveries which we will share with you throughout this webinar, which we are running in collaboration with IHCAN.

Learning Objectives
  • How to use ‘systems theory’ thinking to view the human microbiome as a dynamic and contextually-rich ecosystem.
  • The importance of the GI immune system – including inflammation and antimicrobial peptides in health and disease.
  • Understand the role of ‘syntrophy’ in short-chain fatty acid (SCFA) production by commensal bacteria.
  • Learn more about the importance of Bacteroides species – the good, the bad and the ugly.
  • Understand the different roles of key Ruminococcus species in health and disease.
  • Learn about novel microbes and mycology involvement as triggers for inflammatory pathways and IBD in the GI tract.
  • The importance of molecular methodologies and endogenous gene controls in mapping the human microbiome.
  • Learn about the new comprehensive GI EcologiX™ microbiome profile from our CQC-registered UK microbiome laboratory.

Speakers


  • Humphrey Bacchus

    Humphrey Bacchus is the MD at Invivo Healthcare, and founder of the UK-based microbiology lab, Phylo Bioscience. His vision for the laboratory was to develop multiple host-microbiome clinical diagnostics for healthcare professionals. His research interests focus on the microbiome-immune interface and its role in health and disease. Under his guidance, Phylo Bioscience has commercially developed and brought to market microbiome profiles assessing the gastrointestinal, oral and vaginal ecosystems, whilst also conducting research work into the oral-gut microbiome and the pathogenesis of neurodegenerative disorders.

Related Articles

GI Microbiome, Microbiome 101, Microbiome Basics, Supplements
Prebiotics: You are what your microbes eat.

At Invivo we pride ourselves in translating the wealth of complex information around the GI microbiome into clinical relevance. Client outcomes govern what we do and with this in mind, ...

GI Microbiome, Neurological
Mood & The Microbiome

For many years, mental health was thought to be only a problem of the mind, and not linked to the processes and functioning of the body that houses the mind. ...

GI Microbiome, Immunology & Inflammation
IBD & The Microbiome

The range of disorders cumulatively known as IBD affects many people across the UK, and the human microbiome is involved in more ways than one. The question is, what can ...

1